Profile data is unavailable for this security.
About the company
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
- Revenue in CAD (TTM)-16.37k
- Net income in CAD-2.67m
- Incorporated2006
- Employees--
- LocationSirona Biochem Corpc/o WeWork, 595 Burrard St.VANCOUVER V7X 1L4CanadaCAN
- Phone+1 (604) 641-4466
- Fax+1 (604) 608-5471
- Websitehttps://www.sironabiochem.com/